1. New LDL-C Lipid Targets

3. NCEP ATP III Clinical Trial Update

4. PROVE IT-TIMI 22 Intensive vs Moderate Statin Therapy After ACS

6. Early Nonstatin Trials of Lowering Cholesterol Levels

7. Lower Risk of CV Events Via Multiple Genetic Variants Affecting LDL-C Levels

8. JUPITER and TNT Trials Evidence That Lower LDL-C Is Better

9. 2013 ACC/AHA Cholesterol Guidelines 4 Statin Benefit Groups Identified

11. IMPROVE-IT vs CTT Ezetimibe vs Statin Benefit

14. The PCSK9 Variant Story

18. Lipid Treatment Strategies ODYSSEY OPTIONS I Randomized Trial

20. PCSK9 Inhibitors Case of 68-year-old Man

21. Abbreviations

22. References

23. References (cont)

24. References (cont)